D1 dopamine receptor modulators (NINDS/NIH/National Center for Advancing Translational Sciences/University of North Carolina)

N/A

Report date: 2025/06/11 10:34:05
NME

Base Information

Drug NameD1 dopamine receptor modulators (NINDS/NIH/National Center for Advancing Translational Sciences/University of North Carolina)
Drug Alias NameMLS-1082MLS-6585
ClassificationSmall molecules
Mechanisms of ActionDopamine D1 receptor modulators
TargetsDopamine D1 receptor
Therapy Area/IndicationsSchizophreniaAlzheimer DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of North Carolina, GreensboroNational Institutes Of HealthNational Institute Of Neurological Disorders And Stroke
Inactive CompaniesNational Center For Advancing Translational Sciences
Active IndicationsParkinson Disease
Inactive IndicationsSchizophreniaAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A